Yoshihiro Takai
Osaka University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshihiro Takai.
Investigative Ophthalmology & Visual Science | 2013
Shizuka Koh; Naoyuki Maeda; Chikako Ikeda; Yoshihiro Takai; Hisataka Fujimoto; Yoshinori Oie; Takeshi Soma; Motokazu Tsujikawa; Kohji Nishida
PURPOSE To investigate the effects of viscosity and suspensibility of eyedrops for dry eye by evaluating an eyedrop with one of the solutions or no solution (0.3% sodium hyaluronate ophthalmic solution, 3% diquafosol ophthalmic solution, and 2% rebamipide ophthalmic suspension) on ocular higher-order aberrations (HOAs) and forward light scatter. METHODS We evaluated ocular HOAs and forward light scatter before and 1, 5, and 10 minutes after instillation of three eyedrops for dry eye in 15 healthy subjects. Saline served as the control. The HOAs were measured for a 4-mm pupil using a wavefront sensor. The obtained aberration data were analyzed in the central 4-mm diameter for total HOAs up to the sixth-order Zernike polynomials. Forward light scatter was quantified with a straylight meter. RESULTS A significant increase was seen in the HOAs 1 minute after instillation of the three eyedrops for dry eye; the HOAs recovered to the baseline level thereafter. When 0.3% sodium hyaluronate was compared with 2% rebamipide and 3% diquafosol, the HOAs increased significantly (P < 0.01 for both comparisons) immediately after instillation. A significant increase in forward light scatter occurred 1 minute after instillation of rebamipide suspension and returned to the preinstillation level 5 minutes after instillation. No significant changes in forward light scatter occurred after instillation of 3% diquafosol or 0.3% sodium hyaluronate. CONCLUSIONS Quantitative serial measurement of HOAs and forward light scatter showed that the temporal reduction in optical quality may be attributed mainly to increased HOAs after instillation of highly viscous 0.3% sodium hyaluronate ophthalmic solution and to increased forward light scatter after instillation of 2% rebamipide ophthalmic suspension in healthy subjects.
Journal of Neurochemistry | 2012
Takeshi Shimada; Yoshihiro Takai; Kikuko Shinohara; A. Yamasaki; Keiko Tominaga-Yoshino; Akihiko Ogura; Akihiro Toi; Kouji Asano; Norihito Shintani; Atsuko Hayata-Takano; Akemichi Baba; Hitoshi Hashimoto
J. Neurochem. (2012) 122, 81–93.
Japanese Journal of Ophthalmology | 2013
Shizuka Koh; Chikako Ikeda; Yoshihiro Takai; Hitoshi Watanabe; Naoyuki Maeda; Kohji Nishida
Archive | 2013
Takahiro Kurose; 孝弘 黒瀬; Takayuki Miyano; 貴之 宮野; Mariyo Kato; 万里代 加藤; Yoshihiro Takai; 良宏 高井
American Journal of Ophthalmology | 2017
Shizuka Koh; Yasushi Inoue; Shintaro Ochi; Yoshihiro Takai; Naoyuki Maeda; Kohji Nishida
Archive | 2014
Takahiro Kurose; Yoshihiro Takai; Takayuki Miyano; Yusuke Takeuchi
Archive | 2013
Takayuki Miyano; Takahiro Kurose; Mariyo Kato; Yoshihiro Takai
Archive | 2013
Takahiro Kurose; 孝弘 黒瀬; Takayuki Miyano; 貴之 宮野; Mariyo Kato; 万里代 加藤; Yoshihiro Takai; 良宏 高井
Archive | 2013
Takahiro Kurose; Takayuki Miyano; Mariyo Kato; Yoshihiro Takai
Investigative Ophthalmology & Visual Science | 2013
Shizuka Koh; Naoyuki Maeda; Chikako Ikeda; Yoshihiro Takai; Hisataka Fujimoto; Yoshinori Oie; Takeshi Soma; Motokazu Tsujikawa; Kohji Nishida